Discover 874 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Indianapolis focus on numerous chronic conditions such as lupus, heart disease, and dystrophy. The city’s leading healthcare institutions are actively recruiting participants seeking paid clinical research opportunities as a healthy volunteer, as well as those looking for studies related to a particular health condition to help advance medical knowledge and treatment options in these critical areas.
Filter
2
Filter results
Results: 874
Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
for
Metabolically Healthy Obesity
Location: Muncie IN
Sponsor: Ball State University
Sex: All
Age: 18 - 55
Code: NCT07559227
Recruiting
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
for
Metabolic Syndrome, Healthy Participants,
Location: Muncie IN
Sponsor: Ball State University
Sex: All
Age: 18 - 55
Code: NCT07095426
Recruiting
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
for
Healthy Participants
Location: Muncie IN
Sponsor: Ball State University
Sex: All
Age: 18 - 45
Code: NCT07045051
Recruiting
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: Lafayette IN, Edgewood KY, Fort Wayne IN, Lisle IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase3, Recruiting
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
for
Non-small Cell Lung Cancer
Location: Lafayette IN, Roanoke VA, Birmingham AL, Rochester NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07190248
Phase3, Recruiting
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
for
Relapsed or Refractory Hematologic Malignancies
Location: Lafayette IN, Fairway KS, Washington DC, Hackensack NJ,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03838926
Phase1, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: Indianapolis IN, Cincinnati OH, Lexington KY,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Indianapolis IN, Mason OH, Caledonia MI, Clarkston MI,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
Featured
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Indianapolis IN, Peoria IL, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT06332534
Phase3, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Indianapolis IN, Cleveland OH, London, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT05995353
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Indianapolis IN, Fort Wayne IN, Louisville KY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Featured
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration